Block 5, B Area
No. 777 Binhai 4th Road Hangzhou Bay New Area
Ningbo
China
86 57 4639 35666
https://www.jenscare.com
Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 376
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Shiwen Lv | Chairman, CEO & CTO | 3.14M | N/A | 1969 |
Mr. Fei Pan | CFO, VP & Executive Director | 3.67M | N/A | 1985 |
Mr. Yuanyuan Li | Joint Company Secretary | N/A | N/A | 1986 |
Mr. Wai Chiu Wong FCS | Joint Company Secretary | N/A | N/A | 1956 |
Mr. Biao Li | Vice President | 498.87k | N/A | 1985 |
Mr. Bo Hu | IT Director & Supervisor | N/A | N/A | 1990 |
Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of invasive interventional therapies for structural heart diseases in the People's Republic of China. The company offers LuX-Valve, a transcatheter tricuspid valve replacement (TTVR) product candidate for the treatment of severe tricuspid regurgitation and high surgical risk; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. Its products have applications in the treatment of structural heart diseases, including tricuspid valve diseases, aortic valve diseases, mitral valve diseases, and heart failure. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China.
Jenscare Scientific Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.